Amarin CEO Discusses Vascepa's Expanded Labeling on CNBC

Posted in Biotech

December 16, 2019 • 2 min read

This past Friday, Amarin received FDA approval for a new indication and label expansion for VASCEPA (icosapent ethyl) capsules. With the approval VASCEPA is now the first and only drug approved by the FDA...

Charles River Laboratories to Acquire HemaCare Corporation

Posted in Biotech

December 16, 2019 • 2 min read

Charles River Laboratories International, Inc. (NYSE: CRL) and HemaCare Corporation (OTCMKTS: HEMA) announced today a definitive agreement for Charles River to acquire HemaCare for approximately $380 million in cash...